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Abstract 25 
Pathogenic Shigella spp. are the leading cause of bacterial dysentery, with Shigella flexneri 26 
and Shigella sonnei accounting for around 90 % of cases worldwide. While S. flexneri causes 27 
most disease in low-income countries (following ingestion of contaminated food and/or 28 
water), S. sonnei predominates in wealthy countries and is mainly spread from person-to-29 
person. Although both species contain a large virulence plasmid, pINV, that is essential for 30 
the organism to cause disease, little is known about its maintenance. Here, using a 31 
counterselectable marker within the virulence-encoding region of pINV, we show that the S. 32 
flexneri plasmid is less stable than that of S. sonnei, especially at environmental 33 
temperatures. GmvAT, a toxin-antitoxin system, is responsible for the difference in stability, 34 
and is present in pINV from S. flexneri but is absent in S. sonnei pINV; GmvT is an 35 
acetyltransferase toxin that inhibits protein translation. Loss of GmvAT and a second toxin-36 
antitoxin system, CcdAB, from pINV reduces S. sonnei plasmid stability outside the host, 37 
reflecting the host-adapted lifestyle and person-to-person transmission of this species, and 38 
hence the striking differences in its epidemiology. 39 
 40 
Many critical functions in bacteria, including antibiotic resistance and virulence, are encoded 41 
on plasmids1 which establish long-standing associations with particular bacterial lineages, 42 
even though they can impose fitness costs on their bacterial host. Human pathogens such as 43 
Shigella spp., Salmonella enterica and Yersinia spp. harbour plasmids which are essential for 44 
pathogenesis1-4, although little is known about the mechanisms of plasmid maintenance 45 
that lead to the retention of a functional plasmid, and how they are adapted to the lifecycle 46 
of these important human pathogens. 47 
 48 
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Shigella spp. are an important cause of bacillary dysentery that have emerged from 49 
Escherichia coli on several occasions following the acquisition of a single copy 210 kb 50 
plasmid, pINV5. The plasmid contains a pathogenicity island (PAI) of ~ 30 kb that encodes a 51 
Type III Secretion System (T3SS) essential for virulence, as well as effector molecules and 52 
regulatory proteins6,7. The Shigella T3SS acts as a molecular syringe that delivers effectors 53 
into host cells8,9 and mediates entry of the bacterium3,8. During in vitro growth, Shigella 54 
flexneri can lose the PAI or the entire plasmid, which results in increased growth rate10, 55 
highlighting the fitness cost of pINV in S. flexneri (pINVSf). 56 
 57 
S. sonnei and S. flexneri cause the overwhelming majority of shigellosis worldwide11,12. 58 
Within less wealthy countries, S. flexneri infections are more common than S. sonnei11,13, 59 
and are typically acquired from contaminated food or water14. In contrast, S. sonnei 60 
accounts for over 70 % of disease in wealthy countries11. In this setting, S. sonnei is mainly 61 
spread by direct person-to-person contact between individuals in close proximity, such as 62 
children in playgroups, men having sex with men (MSM), and those living in institutions15-19. 63 
As countries have improved their sanitation and water supply, S. sonnei has often displaced 64 
S. flexneri as the main cause of shigellosis12,20-22. 65 
 66 
Since pINV is non-conjugative and present in single copy6, maintenance systems must exist 67 
to prevent its loss from Shigella. To date, these have only been studied in S. flexneri pINVSf 68 
which encodes MvpAT, a VapBC-family toxin-antitoxin (TA) system7,23,24. TA systems consist 69 
of a toxin and a cognate antitoxin which prevents its activity. The toxin is relatively stable, 70 
whereas the antitoxin is specifically degraded by cellular proteases such as Lon25,26. If the 71 
genetic element encoding a TA system is lost during cell division, the pool of antitoxins is 72 
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degraded, leading the toxin to inhibit bacterial viability. MvpT is an RNAse that targets 73 
tRNAfMet and stalls translation24, promoting post-segregational killing of bacteria which have 74 
lost pINVSf23,27.  75 
 76 
Little is known about the maintenance of pINV in other species of Shigella, even though they 77 
have different modes of spread and capacity to cause disease while sharing the same 78 
virulence plasmid. Here we sought to define the mechanisms of pINV stability in S. flexneri 79 
and S. sonnei at temperatures found within and outside the human host. Here we examined 80 
the loss of the PAI and/or the entire plasmid, as both have a profound effect on 81 
host:pathogen interactions (through absence of the T3SS) and both are examples of plasmid 82 
instability that occur during growth10. To achieve this, we introduced a counterselectable 83 
marker into the PAI to report the loss of Shigella virulence. We show that discrete deletions 84 
in S. sonnei pINV impair its stability especially in environmental temperatures and reflect its 85 
recent emergence as a host-adapted pathogen.  86 
 87 
Results 88 
pINV stability differs in S. flexneri and S. sonnei 89 
Plasmid stability (i.e. maintenance of the PAI and/or the entire plasmid) in S. flexneri and S. 90 
sonnei can be detected on solid media containing Congo red dye. When the T3SS is 91 
functional, S. flexneri colonies appear red, while avirulent bacteria, which lack either the 92 
PAI, its activator VirF (which is encoded outside the PAI6) or pINV entirely, form large white 93 
colonies28 (Fig. 1a). Similarly, “Phase II” colonies of S. sonnei which do not express the T3SS 94 
are larger and paler than “Phase I” S. sonnei containing pINVSs; loss of the O antigen capsule 95 
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locus from S. sonnei pINVSs also changes the colony morphology and leads to a ‘rough’ 96 
phenotype29,30  which can be detected as sectored colonies (Fig. 1a). 97 
 98 
Initially we used colony morphology to compare pINV stability in S. flexneri M90T and S. 99 
sonnei 53G. Bacteria were grown on solid media for ~ 25 generations at selected 100 
temperatures, and individual colonies were then resuspended and plated to media 101 
containing Congo red (Fig. 1b). At 37oC, pINV stability was over two orders of magnitude 102 
higher in S. flexneri than S. sonnei, consistent with previous reports29,31. We also observed 103 
no difference in the stability of pINV in S. flexneri at 37oC and 21oC, temperatures found in 104 
the mammalian host and external environment, respectively (Fig. 1b; p = 0.7819). This 105 
finding is in contrast to work that measured the emergence of PAI-negative bacteria during 106 
liquid growth over 40 generations, although results may have been confounded by the 107 
increased growth rate of avirulent bacteria at higher temperatures27,32, which could 108 
outgrow wild-type bacteria in these circumstances. In contrast to S. flexneri, pINV stability in 109 
S. sonnei was markedly influenced by the ambient temperature, and was over an order of 110 
magnitude more stable at 37oC than 21oC (Fig. 1b, p = 0.0015). Similar results were observed 111 
with S. sonnei CS20, which belongs to a genetic lineage that has shown enhanced worldwide 112 
spread in the last hundred years and is phylogenetically distinct from S. sonnei strain 113 
53G33,34 (Supplementary Fig. 1, p < 0.0001 for stability between 37oC and 21oC). 114 
 115 
The use of colony morphology to assess pINV stability can be confounded by the rapid 116 
replication of bacteria lacking the PAI (which can outgrow wild-type bacteria in mixed 117 
populations32), and the difficulty detecting rare instances of plasmid instability. To 118 
circumvent these issues, we introduced a sacB-neoR marker into mxiH, which is located on 119 
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the PAI and encodes the needle subunit of the T3SS35, in pINVSf and pINVSs. The marker 120 
allows selection of bacteria retaining the PAI (by kanamycin resistance), and those which 121 
have lost the PAI (growth on media containing sucrose). In pilot experiments, sacB and virB 122 
could not be amplified by PCR from 100/100 sucrose-resistant S. flexneri and S. sonnei 123 
colonies, indicating a false positive rate of < 1 %. We also found that the mxiH::sacB-neoR 124 
strains have the same growth rate as their wild-type parental strains (Supplementary Fig. 2, 125 
p = 0.7552 and 0.6368 for S. flexneri and S. sonnei, respectively). Furthermore, levels of pINV 126 
stability in S. flexneri and S. sonnei measured using loss of mxiH::sacB-neoR were comparable 127 
to those detected on Congo red (Fig. 1c-d), except the limit of detection for PAI loss was 128 
lower (~ 10-4 and 10-7 for assays using Congo red and mxiH::sacB-neoR, respectively). 129 
Consistent with Congo red assays, temperature does not influence pINVSf stability in assays 130 
with strains containing the mxiH::sacB-neoR marker (Fig. 1c, p = 0.9465). Furthermore, 131 
pINVSs is significantly more stable at 37°C compared with lower temperatures (Fig. 1b & 1d, 132 
p < 0.001) and colony sectoring in S. sonnei significantly increases as growth temperature 133 
decreases in both S. sonnei 53G and its mxiH::sacB-neoR derivative (Supplementary Fig. 3). 134 
These data validate the use of mxiH::sacB-neoR to accurately quantify PAI stability, and 135 
confirm the effect of temperature on pINV stability in S. flexneri and S. sonnei. 136 
 137 
S. flexneri pINVSf harbours three functional TA systems  138 
Previous work demonstrated that the TA system MvpAT encoded on pINVSf contributes to 139 
plasmid stability at 37oC23,27. Consistent with this, we found that deletion of mvpAT leads to 140 
a marked reduction in pINVSf stability at 37°C (Fig. 1c, 16-fold reduction, p < 0.0001). At 141 
30°C, the effect of deleting mvpAT was less marked but was still significant (p = 0.0015), 142 
while loss of mvpAT does not influence pINVSf stability at 21oC (p = 0.9995). 143 
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 144 
To determine the mechanisms conferring pINV stability at environmental temperatures, we 145 
analysed the sequence of pINVSf, and found four putative TA systems in addition to MvpAT. 146 
ccdAB is closely related to a TA system on the E. coli F plasmid (90.9 % nucleotide identity)36, 147 
while ORFs 0062-3, 0111-2 (gene numbers from pWR5017) and yacAB are previously 148 
uncharacterised. 0062 and 0111 are both predicted to encode GCN5-related N-149 
acetyltransferases (GNATs), which use acetyl-CoA as a donor to acetylate target molecules, 150 
while the adjacent genes, 0063 and 0112, encode potential antitoxins with predicted DNA-151 
binding domains, which could mediate autoregulation as seen with other TA systems37. The 152 
yacA product is a member of the RelB/DinJ-like antitoxin family, although yacB has a 153 
frameshift mutation that leads to a premature stop codon. We also identified a gene (0205) 154 
encoding a potential RelB-like antitoxin. 155 
 156 
To determine whether these TA systems are functional, each gene was expressed in S. 157 
flexneri BS176 (which lacks pINV38) using an arabinose-inducible promoter. As expected, 158 
none of the predicted antitoxins (mvpA, ccdA, yacA, 0063, 0112 and 0205) affected bacterial 159 
survival when expressed (Supplementary Fig. 4) while expression of mvpT dramatically 160 
impaired bacterial viability (Fig. 2a). In addition, induction of ccdB or 0062 significantly 161 
reduced bacterial survival at 21°C and 37°C (Fig. 2b, 2c and Supplementary Fig. 5, two-way 162 
ANOVA p < 0.0001), while expression of yacB and 0111 did not affect viability 163 
(Supplementary Fig. 4). We next introduced amino acid substitutions into MvpT (D7A24), 164 
CcdB (W99S, G100E and I101K39, generating CcdBSEK) and 0062 (G103D) to impair their 165 
known/predicted activities; the modification in 0062 is predicted to abolish acetyl-CoA 166 
binding, and hence its ability to acetylate its target(s)40. In each instance, the substitutions 167 
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abolished the toxicity of the proteins (Fig. 2). Additionally, bacterial death was prevented by 168 
co-expression of mvpA, ccdA and 0063 with their corresponding toxins (Fig. 2). Taken 169 
together these results confirm that 0062/0063 is a functional TA system (like mvpAT and 170 
ccdAB)  and was designated as GmvAT (for GNAT maintenance of virulence antitoxin/toxin) 171 
due to its predicted biochemical function. 172 
 173 
GmvAT stabilises pINVSf at environmental temperatures 174 
To determine the contribution of mvpAT, ccdAB and gmvAT to pINVSf stability, we 175 
constructed strains lacking these TA systems either individually or in combination in S. 176 
flexneri, and assessed plasmid stability at 21°C and 37°C. At 37°C, mvpAT is necessary and 177 
sufficient for pINVSf stability (Fig. 3a), as shown previously27; deletion of ccdAB and gmvAT 178 
alone or together has no impact on pINVSf stability at this temperature (each deletion vs. 179 
wild-type, p > 0.9999). In contrast, at 21°C, GmvAT was sufficient for plasmid stability (Fig. 180 
3f, GmvAT alone vs. wild-type, p > 0.9999). However, MvpAT and CcdAB in combination can 181 
compensate for the absence of gmvAT at 21°C (p = 0.5596), demonstrating redundancy 182 
between the TA systems at this temperature. CcdAB only affects pINVSf stability at 37°C in 183 
the absence of MvpAT (p < 0.02) or at 21°C in the absence of both other TA systems (p = 184 
0.0049). qRT-PCR analysis of gmvA and mvpA indicated that there was no significant 185 
difference between expression of these two TA systems at 21°C relative to 37°C, so the 186 
effect of temperature is likely to operate at a post-transcriptional level (Supplementary Fig. 187 
6, p = 0.4783). Overall, these data demonstrate that MvpAT is responsible for the stability of 188 
S. flexneri pINVSf at 37oC, while GmvAT is the only TA system that is sufficient for pINVSf 189 
stability at environmental temperatures. 190 
 191 
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GmvT is a novel acetyl transferase that inhibits protein translation  192 
In E. coli, GNATs modify a variety of targets including RNA polymerase and ribosomal 193 
proteins41 using acetyl-CoA as a donor, while many TA system toxins affect protein 194 
synthesis24,42,43. To examine the mechanism of action of GmvT and whether it affects 195 
transcription and/or translation, we generated linear DNA templates of His-tagged GmvT 196 
and GmvTG103 as templates for in vitro transcription/translation assays (Fig. 4a). The 197 
production of GmvT was not detected either by Coomassie staining or Western blot analysis 198 
in reactions containing the template for the wild-type protein and acetyl-CoA, but was 199 
detected in reactions lacking the acetyl donor. In contrast, GmvTG103D was generated in 200 
reactions with or without acetyl-CoA (Fig. 4a). To define the step inhibited by GmvT, we 201 
measured levels of gmvT-specific mRNA produced in the reactions (Fig. 4a); gmvT mRNA 202 
was detected in all reactions regardless of the nature of the template or the presence of 203 
acetyl-CoA. Additionally we purified mRNA generated from in vitro transcription reactions 204 
using gmvT as the DNA template, then added a fixed amount of mRNA (2.5 µg) to 205 
translation reactions with or without acetyl-CoA (Fig. 4b). GmvT was produced only in 206 
reactions lacking acetyl-CoA. Finally, we examined the effect of GmvT on a second DNA 207 
template (encoding sfGFP) in in vitro transcription/translation reactions. The band 208 
corresponding to GFP was markedly reduced only in reactions that contained both acetyl-209 
CoA and functional GmvT (Fig. 4c). Taken together, these results demonstrate that GmvT is 210 
an acetyl-CoA dependent GNAT that blocks protein translation. 211 
 212 
Distinct mechanisms of pINV maintenance in S. sonnei and S. flexneri  213 
To define the mechanisms underlying the distinct behaviours of pINV in S. flexneri and S. 214 
sonnei, we examined the plasmid sequences. Of note, pINVSs from S. sonnei 53G entirely 215 
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lacks gmvAT (as part of a 4.9 kb deletion) and ccdB, although 23 nucleotides of ccdA remain 216 
(Fig. 5). To determine whether the absence of these TA systems accounts for the difference 217 
in pINV stability between S. flexneri and S sonnei, we introduced ccdAB and gmvAT 218 
individually or together into S. sonnei pINVSs at sites corresponding to their positions in S. 219 
flexneri (generating S. sonnei ccdWTgmvWT, Fig. 5b); strains with non-functional toxins in the 220 
same loci were also constructed (generating S. sonnei ccdSEKgmvG103D). As expected, the non-221 
functional TA systems had no impact on pINVSs stability at all temperatures tested 222 
(Supplementary Fig. 7). Of note, we found that insertion of functional gmvAT into the S. 223 
sonnei pINVSs is sufficient to stabilise pINVSs at 37°C to pINVSf levels (Fig. 5c, p < 0.0001); 224 
ccdAB does not increase stability at this temperature. At 21°C, gmvAT has an even more 225 
dramatic effect, stabilising S. sonnei pINVSs by over 200-fold (p < 0.0001), while ccdAB has a 226 
minor contribution only in the presence of gmvAT (p = 0.0176). Furthermore, introduction 227 
of both functional TA systems stabilised pINVSs to levels that are not statistically different 228 
from pINVSf at 37°C and 21°C (Fig. 5c and Supplementary Fig. 8, p = 0.4677 and 0.3958, 229 
respectively). PAI retention could result from increased plasmid stability in a sub-population 230 
of bacteria. Therefore we measured PAI-loss in cells that had retained the PAI in an initial 231 
assay; there was no significant difference in the rate of PAI-loss between the initial and 232 
subsequent assays (Supplementary Fig. 9; p > 0.08). Furthermore, deletion of TA systems 233 
from S. flexneri or their introduction into S. sonnei did not significantly affect the fitness of 234 
bacteria (Supplementary Fig. 10). These results demonstrate that the absence of gmvAT 235 
(and to a lesser extent ccdAB) in S. sonnei 53G accounts for the reduced stability of pINVSs at 236 
environmental temperatures, and the difference in plasmid stability between S. flexneri and 237 
S. sonnei. 238 
 239 
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The role of the TA systems in maintenance of virulence was confirmed by introducing 240 
GmvAT and CcdAB into a wild-type S. sonnei strain, then using Congo red, rather than 241 
sucrose selection, to detect the emergence of avirulent (PAI-negative) bacteria during 242 
growth at 21°C. Over 48 generations, the number of virulent bacteria in S. sonnei 53G 243 
cultures fell to approximately 40 %, whereas it remained above 98 % in the TA+ mutant (Fig. 244 
6a, p < 0.0001). We also analysed the ability of bacteria to form plaques in epithelial cell 245 
monolayers which measures their invasive capacity, intracellular replication, and cell-to-cell 246 
spread44. S. sonnei 53G had a significantly reduced ability to form plaques following passage 247 
at 21°C compared (Fig. 6b, p = 0.0009), whereas the number of plaques formed by S. sonnei 248 
ccdWTgmvWT strain did not change over time (p = 0.9442), demonstrating that the loss of 249 
virulence during growth at 21°C was impaired by insertion of the TA systems. 250 
 251 
gmvAT and ccdAB were lost from pINVSs soon after the emergence of S. sonnei 252 
Given their role in plasmid maintenance, we examined available Shigella genome sequences 253 
for the presence of ccdAB, gmvAT and mvpAT. In Shigella boydii (strains Sb227 and CDC 254 
3083-94) and Shigella dysenteriae (Sd197 and 1617), all three TA systems are present. 255 
Similarly, in a collection of S. flexneri isolates45, we found that all strains with ≥ 45% 256 
sequence coverage of pINVSf (over 200 isolates) possess ccdAB, gmvAT and mvpAT. In 257 
contrast, ccdAB or gmvAT were not detected by BLAST in the genome of any of 132 S. sonnei 258 
strains isolated across four continents worldwide between 1948 and 200833. However only 259 
46 of 132 isolates have ≥ 90% sequence coverage of pINV. Of these 46 strains, 41 contain 260 
the identical gmvAT deletion as in S. sonnei 53G, and 38 isolates have the same 23 bp ccdA 261 
fragment. The remaining strains either have larger deletions or insufficient sequence for 262 
analysis.  263 
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 264 
The ccd deletion is seen across all three phylogenetic lineages of S. sonnei, including the 265 
oldest lineage, lineage I. Lineage II and III strains harbour the same gmv deletion although 266 
there is insufficient available sequence to define the nature of the loss in lineage I strains. 267 
Therefore, there are specific, discrete deletions of ccdAB and gmvAT present across the 268 
entire phylogenetic tree of S. sonnei, indicating that these TA systems were each lost from 269 
pINV on a single occasion soon after S. sonnei diverged from E. coli. 270 
 271 
Discussion 272 
Acquisition of pINV was a critical step in the evolution of Shigella spp., enabling bacteria to 273 
invade epithelial cells using the plasmid-encoded T3SS3,46. Shigella spp. have subsequently 274 
adapted to their pathogenic lifestyle by a series of chromosomal deletions, resulting in the 275 
loss of catabolic functions and motility5,46. S. sonnei differs from other Shigella spp. as it is 276 
largely responsible for disease in industrialised countries with the bacterium usually 277 
acquired direct from another infected individual rather than from an environmental 278 
source15-18. We show that two unique genetic events have led to the loss of TA systems from 279 
pINV in S. sonnei and its reduced capacity to maintain the plasmid and/or the PAI while in 280 
the external environment. These discrete deletions reflect the ongoing transition of S. 281 
sonnei into an obligate pathogen that is less dependent on survival outside a mammalian 282 
host than other species of Shigella. The presence of genes encoding an O-antigen 283 
capsule30,47 on S. sonnei pINV is a further adaptive change in the plasmid of a bacterium that 284 
maintains an intimate relationship with its host, as the capsule promotes resistance to 285 
complement-mediated killing and lowers the inflammatory response47.  286 
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 287 
GNATs are a highly abundant family of proteins found in all domains of life41 and GmvT is 288 
the first example of a GNAT that stabilises a mobile genetic element through inhibition of 289 
protein translation. GmvT might have similar activity to TacT, which is a chromosomally-290 
encoded GNAT that mediates persister formation in Salmonella by acetylation of aminoacyl-291 
tRNA48. We show that GmvAT is sufficient for retention of the S. flexneri invasion plasmid 292 
and/or the PAI at temperatures that would be encountered outside of the human host. 293 
Critical virulence functions conferred by pINV are under precise regulatory control, and 294 
triggered by environmental cues such a temperature49 and oxygen50. Our work 295 
demonstrates that the mechanisms of maintenance of pINV are also influenced by specific 296 
signals, and are tailored to the distinct lifestyles of different Shigella spp. 297 
  298 
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Methods 299 
 300 
Strains and growth media 301 
Bacterial strains and plasmids used in this study are shown in Supplementary Table 1. 302 
Unless otherwise stated, E. coli and Shigella were grown in lysogeny broth (LB; Invitrogen, 303 
Waltham, MA), or on solid media containing 1.5 % (w/v) agar (Oxoid, Basingstoke, UK). 304 
Antibiotics were used at the following concentrations: carbenicillin, 50 µg/ml; 305 
chloramphenicol, 20 µg/ml; kanamycin, 50 µg/ml. Congo red dye (0.01 % w/v, final 306 
concentration) was added to tryptic soy broth (Fluka, Buchs, Switzerland) plus agar. For 307 
selection on sucrose, 1 % (w/v) tryptone (Fluka), 0.5 % (w/v) yeast extract (Fluka) and agar 308 
as above were autoclaved in water, and sucrose was added to a final concentration of 10 % 309 
(w/v). 310 
 311 
Genetic manipulation of S. flexneri and S. sonnei 312 
DNA constructs were assembled into plasmids (Supplementary Table 1) in E. coli DH5α 313 
using NEBuilder HiFi DNA Assembly master mix (New England Biolabs (NEB), Ipswich, MA); 314 
oligonucleotide primers are given in Supplementary Table 2. λ Red recombination51,52 was 315 
employed to construct mutations in Shigella. Approximately 1 kb of flanking sequence was 316 
used to integrate linear fragments into Shigella. For TA restoration in S. sonnei, ccdAB was 317 
positioned at nucleotide position 150,672 of the 53G pINVSs, while gmvAT was inserted at 318 
nucleotide position 40,777 (GenBank HE616529.1). The sacB-neoR cassette was amplified 319 
from pIB27953. 320 
 321 
 322 
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Transductions 323 
P1vir bacteriophage transductions were performed in S. flexneri M90T by adapting a 324 
previously described protocol54. Donor cells were grown overnight in LB at 37°C with 325 
shaking at 180 rpm, then diluted 1/1000 into 10 ml fresh LB plus 0.2 % (w/v) glucose, 5 mM 326 
CaCl2 and grown for 1 hour. P1vir lysate (200 µl) was added to the bacteria and incubated 327 
for 1-4 hours. The clarified lysate was treated with 200 µl chloroform, then the cell debris 328 
was pelleted at 4,500 rpm for 10 minutes. Lastly the supernatant was passed through a 0.45 329 
µm filter and stored at 4°C. Recipient strains were grown overnight in LB, pelleted then 330 
resuspended in 0.5 volumes phage buffer (10 mM CaCl2, 20 mM MgSO4). Phage lysate was 331 
added to 0.1 ml cell suspension at a range of volume ratios (1:100 to 1:1). Mixtures were 332 
incubated without shaking at 37°C for not longer than 30 minutes, after which 1 ml LB 333 
containing 0.1 M sodium citrate was added. Cells were then incubated at 37°C, 180 rpm for 334 
1 hour prior to being pelleted and were then re-suspended in fresh LB + 0.1 M citrate. 335 
Aliquots were spread onto LB agar plates containing appropriate antibiotics. Mutations were 336 
verified by PCR and sequencing. 337 
 338 
Toxicity assays 339 
To assess toxicity of TA-related proteins encoded by pINVSf, strains containing pBAD3355 340 
derivatives encoding inducible toxins and pGM101 derivatives encoding antitoxins were 341 
grown at selected temperatures to OD = 0.1 in LB + 0.2 % (w/v) glucose, then pelleted and 342 
resuspended in LB + 1 % (w/v) arabinose. A serial dilution of each culture in PBS was plated 343 
on LB agar + 0.2 % (w/v) glucose at various timepoints post induction and bacteria were 344 
grown overnight at 37°C to obtain viable counts. Appropriate antibiotics were included in all 345 
media during the assay to maintain the integrity of expression vectors. 346 
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 347 
Virulence plasmid stability assays 348 
pINV stability was measured in two ways: i) analysis of colonies on Congo red and ii) 349 
selection on kanamycin or sucrose in bacteria harbouring mxiH::sacB-neoR. Cells from frozen 350 
stocks were plated on LB agar at selected temperatures and grown for ~ 25 generations. 351 
Individual colonies were suspended in PBS, serially diluted, and plated onto either Congo 352 
red agar, or both to LB plates containing kanamycin and to sucrose plates (to quantify 353 
bacteria without the sacB-neoR cassette). Colonies were discarded from analysis if they were 354 
found to contain ~ 100 % sucrose resistance, indicating a PAI-negative founder. To assess 355 
plasmid instability during longer growth periods in liquid media, cultures were repeatedly 356 
subcultured into fresh LB after reaching stationary phase (e.g. every 24 hours at 21°C). 357 
 358 
Analysis of gene expression and protein synthesis 359 
In vitro transcription was carried out using the MEGAscript T7 kit (Ambion, Basingstoke, UK) 360 
and combined transcription/translation reactions were performed using the PURExpress kit 361 
(NEB), according to manufacturers’ instructions. RNA was extracted from in vitro 362 
transcription reactions using the MEGAclear kit (Ambion) or from exponentially-growing 363 
bacterial cultures using Trizol (Ambion) and ethanol precipitation. Western blots were 364 
carried out using antibodies ab18184 (Abcam, Cambridge, UK) and JL-8 (Clontech, Mountain 365 
View, CA) in phosphate buffered saline containing 5 % (w/v) milk powder and 0.1 % (v/v) 366 
Tween-20. Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) was 367 
conducted according to standard protocols using Power SYBR Green master mix in a 368 
StepOnePlus thermocycler (Applied Biosystems, Foster City, CA). 369 
 370 
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Plaque assay 371 
HeLa cell monolayers were infected with S. sonnei strains by adapting an established 372 
protocol44. HeLa cells were originally obtained from the European Collection of 373 
Authenticated Cell Cultures and were not further authenticated or tested for Mycoplasma 374 
contamination in-house during routine assays. HeLa cells were grown to confluency in high-375 
glucose Dulbecco’s Modified Eagle Medium (DMEM; Sigma-Aldrich, Dorset, UK) containing 376 
10 % heat-inactivated fetal bovine serum (FBS; Gibco, Paisley, UK) in 6-well plates at 37°C, 5 377 
% CO2. Passaged and ancestral S. sonnei strains were subcultured and grown at 37°C with 378 
aeration to mid-exponential phase in brain heart infusion medium (BHI; Oxoid). Bacteria 379 
were added at an appropriate dilution in 200 µl BHI to each well to give a final multiplicity of 380 
infection of 10:1. Plates were then incubated for 90 minutes at 37°C in 5 % CO2 with gentle 381 
rocking every 30 minutes. During this time, 1 % (w/v) low-melt agarose (AGTC Bioproducts, 382 
Fleet, UK) was mixed at a 1:1 ratio with warm DMEM + 10 % FBS, then gentamycin was 383 
added at a final concentration of 20 µg/ml to prevent extracellular bacterial replication. 2 ml 384 
of this mixture was overlaid onto to each well and allowed to set for approximately 45 385 
minutes at room temperature. Plates were incubated at 37°C in 5 % CO2 for 72 hours, after 386 
which plaques were counted under magnification. 387 
 388 
Statistical and computational methods 389 
Log-transformed (normally-distributed) data were analysed using either an unpaired t-test, 390 
linear regression or one-way or two-way ANOVA with Tukey’s multiple comparisons tests as 391 
appropriate (see figure legends). Plasmid alignment diagrams were created using BRIG 392 
v0.9556 and BLAST (blastn) v2.2.29. 393 
 394 
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Data availability 395 
The data that support the findings of this study are available from the corresponding author 396 
upon request. 397 
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Figure Legends 566 
Figure 1. Loss of virulence in S. sonnei is temperature-dependent and higher than in S. 567 
flexneri. a: S. flexneri M90T and S. sonnei 53G grown on Congo red agar showing virulent 568 
bacteria (black arrows), avirulent bacteria (white arrows) and a sectored colony (yellow 569 
arrow). Images are representative of at least three independent experiments. b: Proportion 570 
of avirulent S. flexneri and S. sonnei after ~ 25 generations at the indicated temperatures (n 571 
= 3 cultures in independent experiments): solid line, mean; dotted line, limit of detection 572 
(l.o.d.). Pathogenicity island (PAI) loss in S. flexneri mxiH::sacB-neoR and its ΔmvpAT 573 
derivative (c), and in S. sonnei mxiH::sacB-neoR (d), detected by plating on sucrose and 574 
kanamycin; n = 9 colonies from three independent experiments, except ΔmvpAT at 21°C, n = 575 
7 as two PAI-negative colonies were discarded. **** p < 0.0001; *** p < 0.001; ** p < 0.01, 576 
* p < 0.05; n.s. not significant, one- or two-way ANOVA. Individual bacterial colonies were 577 
grown on nonselective LB agar plates for the stated number of generations, then 578 
resuspended in PBS and plated onto the appropriate media for quantification of either 579 
red/white (b) or kanamycin-/sucrose-resistant colonies (c, d). 580 
 581 
Figure 2. S. flexneri pINV has three functional TA systems. Viability of S. flexneri BS176 582 
following expression of MvpT (a), CcdB (b) or GmvT (c), or modified toxins, ± cognate 583 
antitoxins at 37°C; data shows mean ± s.e.m. (n = 3 cultures in independent experiments). 584 
pControl: empty vector. **** p < 0.0001 by two-way ANOVA. 585 
 586 
Figure 3. S. flexneri pINV TA systems have temperature-dependent effects on plasmid 587 
maintenance. pINVSf stability in mutants lacking TA systems at 37°C (a, b, c) and 21°C (d, e, 588 
f) assessed by loss of mxiH::sacB-neoR. Colonies were grown for ~ 25 generations as 589 
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described previously. **** p < 0.0001; *** p < 0.001; ** p < 0.01; * p < 0.05; n.s. not 590 
significant. Statistical comparisons by one-way ANOVA with Tukey’s multiple comparisons 591 
test (n = 9 colonies from three independent experiments, except ΔmvpAT at 21°C, n = 7 as 592 
two PAI-negative colonies were discarded).  593 
  594 
Figure 4. GmvT blocks translation in an acetyl-CoA dependent manner. a: Products of in 595 
vitro transcription/translation reactions using DNA templates encoding GmvT or GmvTG103D, 596 
or with no template, with or without 100 µM acetyl-CoA (ac-CoA), analysed by SDS-PAGE 597 
and Coomassie staining: GmvT arrowed (upper panel); Western blot analysis with α-His 598 
pAbs to detect GmvT (middle panel); qRT-PCR analysis of mRNA generated in the reactions 599 
above, showing mean ± s.e.m. (n = 2 independent transcription assays, lower panel). b: 600 
Products of in vitro translation reactions following addition of 2.5 µg of purified gmvT 601 
mRNA, analysed by SDS-PAGE and Coomassie staining: GmvT arrowed (upper panel); 602 
Western blot analysis with α-His pAbs (lower panel). c: Products of in vitro 603 
transcription/translation reactions using DNA templates encoding sfGFP and either GmvT, 604 
GmvTG103D or no second protein, with or without 100 µM acetyl-CoA, analysed by Western 605 
blot analysis with α-GFP mAbs. Gels and blots are representative of at least 2 independent 606 
experiments. 607 
 608 
Figure 5. Absence of GmvAT and CcdAB in S. sonnei leads to increased pINV loss. a: 609 
Comparison between S. flexneri M90T pINVSf (AL391753) and S. sonnei 53G pINVSs 610 
(NC_016833). Inner black ring: pINVSf. Selected T3SS- and TA-related ORFs on pINVSf are 611 
indicated as black arrows/boxes. Green outer ring: regions of ≥ 95 % identity of pINVSs to 612 
pINVSf. b: Regions where TA systems were introduced to generate S. sonnei gmvAT (top) and 613 
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ccdAB (bottom) insertion mutants. c: PAI loss in strains with TA insertions grown at 37°C and 614 
21°C for ~ 25 generations as described previously. Insertion of sequences encoding the toxin 615 
(WT) or toxoid (G103D/SEK) are indicated. **** p < 0.0001; * p < 0.05; n.s. not significant by 616 
one-way ANOVA with Tukey multiple comparisons test (n = 9 colonies from three 617 
independent experiments). 618 
 619 
Figure 6. Insertion of CcdAB and GmvAT into wild-type S. sonnei stabilises virulence at 620 
environmental temperatures. S. sonnei 53G, a pINV-cured derivative and a strain carrying 621 
pINV encoding CcdAB and GmvAT were grown for approximately 48 generations at 21°C. a: 622 
Virulent bacteria (forming red colonies) were detected in each culture by plating to Congo 623 
red agar. Data show mean ± s.e.m. (n = 3 cultures in independent experiments). **** p < 624 
0.0001 by two-way ANOVA. b: Epithelial cell monolayers were infected with strains after no 625 
or 48 generations of bacterial growth at 21°C. Plaques (indicating lysis of epithelial cells) 626 
were counted 72 hours post infection. Data show the mean number of plaques per well ± 627 
s.e.m. (n = 4 independent experiments of two wells per strain at each time point). *** p < 628 
0.001; n.s. not significant by two-way ANOVA with Sidak multiple comparisons test. 629 
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Supplementary Figure 1. Stability of pINV
Ss
 is temperature-dependent in multiple strains. 
Proportion of avirulent S. sonnei 53G (lineage II, data from Fig. 1B) and S. sonnei CS20 
(lineage III) after growth for ~ 25 generations at the indicated temperatures; solid line, mean 
(n = 3 independent experiments). Individual bacterial colonies were grown on nonselective 
LB agar plates for the stated number of generations, then were resuspended in PBS and 
plated onto the appropriate media for quantification of red/white colonies. Statistical 
analysis by two-way ANOVA. 
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Supplementary Figure 2. The mxiH::sacB-neoR marker does not significantly affect Shigella 
growth. Growth of S. flexneri M90T (A), S. sonnei 53G (B) and their mxiH::sacB-neoR 
derivatives. Interaction p value calculated by two-way ANOVA (n ≥ 3 from at least three 
independent experiments); n.s. not significant. 
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Supplementary Figure 3. Colony sectoring in S. sonnei is temperature-dependent. 
Proportion of sectored colonies of S. sonnei 53G and its mxiH::sacB-neoR derivative after 
growth for ~ 25 generations at the indicated temperatures; mean ± SEM. **** p < 0.0001; 
*** p < 0.001; n.s. not significant by two-way ANOVA with Tukey’s multiple comparisons test 
(n = 3 independent experiments). 
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Supplementary Figure 4. Several putative TA-related genes on pINV
Sf
 encode non-toxic 
products. Viability of S. flexneri BS176 following expression of putative TA genes at 37°C (A), 
30°C (B) or 21°C (C). CcdB- and CcdB
SEK
-expressing plasmids were included as controls. Data 
(n = 1) are representative of experiments carried out under a range of inducer 
concentrations in various strain/species backgrounds. 
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Supplementary Figure 5. CcdAB, GmvAT and MvpAT toxin-antitoxin pairs function at 30°C 
and 21°C. Strains and experimental conditions are identical to those described in Figure 2A-
C, except for growth temperature. A-C, 37°C; D-F, 21°C. Data shows mean ± SEM (n = 3). 
Two-way ANOVA interaction p < 0.0001 for each data set. 
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Supplementary Figure 6. Expression of gmvAT and mvpAT is not temperature-dependent. 
qRT-PCR analysis of antitoxin gene expression, as a measure of TA operon expression, in cells 
grown at the indicated temperatures. Mean ± SEM shown (n = 3 independent cultures). 
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Supplementary Figure 7. Insertion of non-functional TA operons into pINV
Ss
 does not affect 
plasmid stability. PAI loss in S. sonnei mxiH::sacB-neoR and S. sonnei mxiH::sacB-neoR ccdSEK 
gmvG103D; n.s. not significant by two-way ANOVA with Tukey’s multiple comparisons tests (n 
= 9). 
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Supplementary Figure 8. Inserting S. flexneri ccdAB and gmvAT into S. sonnei 53G pINV is 
sufficient to abolish the difference in plasmid stability between the species. Data 
reproduced from Fig. 1C and 4B for clarity of comparison. PAI loss in S. flexneri mxiH::sacB-
neoR and S. sonnei mxiH::sacB-neoR ccdWT gmvWT, detected by plating on sucrose and 
kanamycin; n.s. not significant by two-way ANOVA with Tukey’s multiple comparisons tests 
(n = 9). 
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Supplementary Figure 9. Retention of the PAI is not due to a sub-population of bacteria. 
Strains were subjected to a standard PAI loss assay (indicated Original, shown as red circles) 
at 37°C (a) or 21°C (b), then a second assay carried out was carried out with PAI+ bacteria 
from the first assay (indicated Passaged, blue circles). S. flexneri ΔTA lacks MvpAT, CcdAB and 
GmvAT, while S. sonnei TA+ has ccdWTgmvWT on pINV. n.s. not significant by two-way ANOVA 
with Tukey’s multiple comparisons tests (n = 9). 
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Supplementary Figure 10. The TA systems do not affect fitness. S. flexneri (a, b) and S. 
sonnei (c, d) mxiH::sacB-neoR strains were competed in co-culture with chloramphenicol-
resistant S. flexneri ΔTA or S. sonnei TA+, in the presence of kanamycin to ensure plasmid 
retention. S. flexneri ΔTA lacks MvpAT, CcdAB and GmvAT, while S. sonnei TA+ has 
ccdWTgmvWT on pINV. After the indicated number of generations at 37°C (a, c) or 21°C (b, d), 
bacteria were plated onto selective media to quantify the ratio of strains. n.s. not significant 
by linear regression analysis (n = 3 independent cultures; error bars show SEM). 
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Supplementary Figure 11. Complete gel and blot images from Figure 4. 
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Supplementary Table 1: Bacterial strains and plasmids. 
 
Strain Name Genotype Reference 
53G S. sonnei lineage II wild-type (29) 
BS176 pINV-cured S. flexneri M90T (38) 
GMCT189 M90T mxiH::sacB-neoR This work 
GMCT197 M90T mxiH::sacB-neoR ΔmvpAT This work 
GMCT198 M90T mxiH::sacB-neoR ΔgmvAT This work 
GMCT199 M90T mxiH::sacB-neoR ΔccdAB This work 
GMCT208 M90T mxiH::sacB-neoR ΔccdAB ΔgmvAT This work 
GMCT209 M90T mxiH::sacB-neoR ΔccdAB ΔmvpAT This work 
GMCT210 M90T mxiH::sacB-neoR ΔgmvAT ΔmvpAT This work 
GMCT213 M90T mxiH::sacB-neoR ΔccdAB ΔgmvAT ΔmvpAT This work 
GMCT215 53G mxiH::sacB-neoR This work 
GMCT232 53G mxiH::sacB-neoR ccdABWT-cat gmvATWT This work 
GMCT233 53G mxiH::sacB-neoR ccdABSEK-cat gmvATWT This work 
GMCT234 53G mxiH::sacB-neoR ccdABWT gmvATG103D-cat This work 
GMCT236 53G mxiH::sacB-neoR ccdABSEK gmvATG103D-cat This work 
GMCT253 M90T mxiH::sacB-neoR ΔclpP::cat This work 
GMCT254 M90T mxiH::sacB-neoR ΔccdAB ΔgmvAT ΔmvpAT ΔclpP::cat This work 
GMCT255 M90T mxiH::sacB-neoR Δlon::cat This work 
GMCT256 M90T mxiH::sacB-neoR ΔccdAB ΔgmvAT ΔmvpAT Δlon::cat This work 
GMCT266 M90T mxiH::sacB-neoR ΔmvpAT Δlon::cat This work 
GMCT267 M90T mxiH::sacB-neoR ΔgmvAT Δlon::cat This work 
GMCT268 M90T mxiH::sacB-neoR ΔccdAB ΔgmvAT Δlon::cat This work 
GMCT269 M90T mxiH::sacB-neoR ΔccdAB ΔmvpAT Δlon::cat This work 
GMCT301 pINV-cured S. sonnei 53G This work 
GMCT364 53G ccdABWT-cat gmvATWT This work 
M90T S. flexneri 5a wild-type (31) 
Plasmid Purpose/Genotype Reference 
pBAD33 Arabinose-inducible expression vector; cat (55) 
pCP20 FLP recombinase for λ Red cassette excision (52) 
pGM085 pBAD33-ccdB This work 
pGM087 pGM101-ccdA This work 
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pGM099 pBAD33-ccdBSEK This work 
pGM101 pTrc99-derived vector compatible with pBAD33; bla This work 
pGM103 pGM101-mvpA This work 
pGM105 pBAD33-ccdA This work 
pGM107 pBAD33-gmvT This work 
pGM109 pBAD33-gmvA This work 
pGM111 pBAD33-pWR501_0111 This work 
pGM113 pBAD33-pWR501_0112 This work 
pGM115 pBAD33-pWR501_0205 This work 
pGM117 pBAD33-pWR501_yacA This work 
pGM119 pBAD33-pWR501_yacB This work 
pGM121 pBAD33-mvpA This work 
pGM123 pBAD33-mvpT This work 
pGM129 pGM101-gmvA This work 
pGM131 pBAD33-gmvTG103D This work 
pGM153 pGM101-pWR501_0112 This work 
pGM163 pBAD33-mvpTD7A This work 
pGM176 pET28a-gmvT-gmvA This work 
pGM178 pET28a-gmvTG103D-gmvA This work 
pIB279 Source of sacB-neoR cassette (53) 
pKD3 Source of camR cassette for λ Red recombination (51) 
pKD46 Helper plasmid for λ Red recombination (51) 
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Supplementary Table 2: Oligonucleotide primers. 
 
Primer 5'-3' Sequence Construct 
GM069 CTGAGGCAAAGAACTCAAATCTTGC 
ΔmxiH::sacB-
neoR 
GM070 CCGGATCCTTTATCCTCACTTATTTTTATC 
ΔmxiH::sacB-
neoR 
GM071 CCCATATGTAATAGGGAGCATTCATG 
ΔmxiH::sacB-
neoR 
GM072 GTTTCTCTTGAACCACCCTGTTTTG 
ΔmxiH::sacB-
neoR 
GM073 CCGGATCCTTTTTAACCCATCAC 
sacB-neoR 
cassette 
GM074 CCCATATGTGCAAGCCTCGTCGT 
sacB-neoR 
cassette 
GM075 CTAGCGAATTCGAGCTTTGCCGATGAGAACAGGGACTG pGM085 
GM076 CCGCCAAAACAGCCATTATATTCCCCAGAACATCAGG pGM085 
GM077 AGGCGAAGCGGCATGGGTACCATTCTCTGTGGG pGM087 
GM078 CCGCCAAAACAGCCATCACCAGTCCCTGTTCTC pGM087 
GM084 CCGCCAAAACAGCCATCGGAAAAGTAAGAACATCAGGTTAATGGCG pGM099 
GM086 GGGAGGCTGTTGGAGCCTATAATG mxiH+ 
GM089 CGCCATTTTCTAACAGTTCAGAAGG mxiH+ 
GM101 CTAGCGAATTCGAGCTAACATTAATTGCATAGCAAATTG pGM109 
GM102 CCGCCAAAACAGCCATTATTTCCATTCAGGCTTTAC pGM109 
GM104 CCGCCAAAACAGCCATCAGACTTTATAAAACAAGGTATTAGGTG pGM107 
GM105 AGGCGAAGCGGCATGCGATGCCTGTTACTGCCA pGM103 
GM106 CCGCCAAAACAGCCATCAGAATGACTCCCTTTCC pGM103 
GM107 CTAGCGAATTCGAGCTAAGCTCCTGTGCAGAATG pGM107 
GM108 CTAGCGAATTCGAGCTCATAAGTATGTTTTTGAGGGC pGM105 
GM109 CCGCCAAAACAGCCAAGCTTCACCAGTCCCTGTTCTC pGM105 
GM110 CTAGCGAATTCGAGCTCTCCACAGAGGTAAATGCC pGM113 
GM111 CCGCCAAAACAGCCAAGCTTACACATCCCATTGAGG pGM113 
GM112 CTAGCGAATTCGAGCTCGAAAAATTGCTGGCAAG pGM111 
GM113 CCGCCAAAACAGCCAAGCTTCTATTGAGGGAGTTTAAGAAAC pGM111 
GM114 CTAGCGAATTCGAGCTCGTAATGCAAATATGCATTATTGTC pGM115 
GM115 CCGCCAAAACAGCCAAGCTTAAGGGACACAGCCTAG pGM115 
GM116 CTAGCGAATTCGAGCTCTATACTGTGTATATACGTGGTAATG pGM117 
GM117 CCGCCAAAACAGCCAAGCTTCATTTATCAGCAATCTTCCTG pGM117 
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GM118 CTAGCGAATTCGAGCTCATGAAATGAGCAGGAAGATTG pGM119 
GM119 CCGCCAAAACAGCCAAGCTTCACAAGAGATTTTCACACAAAATAAC pGM119 
GM120 CTAGCGAATTCGAGCTCAGACATATCCACATAAGGAG pGM121 
GM121 CCGCCAAAACAGCCAAGCTTCAGAATGACTCCCTTTC pGM121 
GM122 CTAGCGAATTCGAGCTCATGCAGGAAAGGGAGTC pGM123 
GM123 CCGCCAAAACAGCCAAGCTTCAGCTCCAGTCTTCAGTTC pGM123 
GM124 
CCTGCGCGATACTCATCATAAACGTATATCCCTTTGACATATCCCGGTATCAATCCCACAATAGATAT
ACACAAGACATATCCACATAAGGAGGCAAATATGTGTAGGCTGGAGCTGCTTC M90T ΔmvpAT 
GM125 
CACCTGGCAGCAGATGCAGCGTCGTGAAGAGGTGAACATCAATGTGCACCGGGAACGCGGGGAGG
ATGTTGAGCCGGGAGATGATTTCTGATGAACAGGATGGGAATTAGCCATGGTCC M90T ΔmvpAT 
GM128 AGGCGAAGCGGCATGCGCATTTCATTATCAAAATCACATTAAAC pGM129 
GM129 CCGCCAAAACAGCCAAGCTTATTTCCATTCAGGCTTTAC pGM129 
GM130 ACCGAAATCATGCCCCTGGGTACAAAC pGM131 
GM131 AGGGGCATGATTTCGGTAAATGGCTACTAAG pGM131 
GM165 AGGCGAAGCGGCATGCTGGTTCAACGACAAGAGC pGM153 
GM166 CCGCCAAAACAGCCAAGCTTACACATCCCATTGAGG pGM153 
GM174 TGTGTAGGCTGGAGCTGCTT cat cassette 
GM175 ATGGGAATTAGCCATGGTCC cat cassette 
GM176 GGTCTTTACCGCATTGAG M90T ΔccdAB 
GM177 AAGCAGCTCCAGCCTACACAGATAAGCCCTCAAAAACATAC M90T ΔccdAB 
GM179 GGACCATGGCTAATTCCCATATGTCAGGCTAGGGTCAAAAATC M90T ΔccdAB 
GM180 AGATTAAGAATGCTTTCCGGG M90T ΔccdAB 
GM183 CTCCACAGGTTACAGACAC M90T ΔgmvAT 
GM184 AAGCAGCTCCAGCCTACACATAACAGAACGCTATACAGAATC M90T ΔgmvAT 
GM186 GGACCATGGCTAATTCCCATTTGTTCAGTCAGTTGTGG M90T ΔgmvAT 
GM187 CTCAGTATGTATCGCTGG M90T ΔgmvAT 
GM201 GTTTATGCTCGCTACCAACATCTG pGM163 
GM202 CAGATGTTGGTAGCGAGCATAAAC pGM163 
GM208 ACGGCCAGTGAATTCGAGCTCGTGAATGACCTGTTTGCC 
53G ccdAB 
insertion 
GM209 TACGCTGCTTCATGATAAGCCCTCAAAAACATAC 
53G ccdAB 
insertion 
GM210 AGGGCTTATCATGAAGCAGCGTATTACTG 
53G ccdAB 
insertion 
GM211 CCATGGCTAATTCCCATTTATATTCCCCAGAACATCAG 
53G ccdAB 
insertion 
GM212 AGCCTACACAATACGGTGCAAACAGGCC 
53G ccdAB 
insertion 
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GM213 CTATGACCATGATTACGCCAAGCTTATGCCATATCTGTGATACATCAG 
53G ccdAB 
insertion 
GM214 TTCCCATTTACTTTTCCGAGAACATCAGGTTAATGGC 
53G ccdABSEK 
insertion 
GM215 CGGAAAAGTAAATGGGAATTAGCCATGGTCC 
53G ccdABSEK 
insertion 
GM216 ACGGCCAGTGAATTCGAGCTCGGCTTCTCCACTGTGATTCCGTCGTG 
53G gmvAT 
insertion 
GM217 AATGAAATGCCACGGCAGCCTGGCGGCT 
53G gmvAT 
insertion 
GM218 GGCTGCCGTGGCATTTCATTATCAAAATCACATTAAAC 
53G gmvAT 
insertion 
GM219 CCATGGCTAATTCCCATTCAGACTTTATAAAACAAGGTATTAG 
53G gmvAT 
insertion 
GM220 AGCCTACACAGTTCAGGTAAACGCCTGTTC 
53G gmvAT 
insertion 
GM221 CTATGACCATGATTACGCCAAGCTTGCGGGTGTAGTAAGCCCT 
53G gmvAT 
insertion 
GM251 CTGGTGCCGCGCGGCAGCCATATGGAAATAAATGTCACCGCG pGM176/8 
GM252 TTTACCGAAATCATGCCCCTGGGTACAAAC pGM178 
GM253 CAGGGGCATGATTTCGGTAAATGGCTACTAAG pGM178 
GM256 AGTGGTGGTGGTGGTGGTGCTTATTTCCATTCAGGCTTTACCG pGM176/8 
GM257 ACATGGTATATCTCCTTCTCAGACTTTATAAAACAAGGTATTAG pGM176/8 
GM258 AAAGTCTGAGAAGGAGATATACCATGTCTACAGCTGCAAGC pGM176/8 
GM261 ACGGCCAGTGAATTCGAGCTCGAAGGCGGTAAAGCGTCTG M90T ΔclpP 
GM262 CCATGGCTAATTCCCATTTCCGTCTCCTGGATAAAATTG M90T ΔclpP 
GM263 AGCCTACACACATCGTAATTGATGCCAGAGG M90T ΔclpP 
GM264 CTATGACCATGATTACGCCAAGCTTCGCTTGCTTTGTCGGACT M90T ΔclpP 
GM267 ACGGCCAGTGAATTCGAGCTCATCATTCAGAAGCTGTTG M90T Δlon 
GM268 CCATGGCTAATTCCCATAGAGCTCTCTCTTAGTTTAATTTC M90T Δlon 
GM269 AGCCTACACATGACCTCGCGCAAAATGC M90T Δlon 
GM270 CTATGACCATGATTACGCCAAGCTTCCCAGTTTCAGCTCACGAG M90T Δlon 
GM302 GCGGTCAGACTGCCAAAAG qRT-PCR mvpA 
GM303 CCGTCTAGCTCTCTCTAATCGGTGTCCGTCGAACCATTCG qRT-PCR mvpA 
GM304 AAACACCGCGAGAACATCAG qRT-PCR gmvA 
GM305 CCGTCTAGCTCTCTCTAATCGGTACGCCAGTTCCATGATGA qRT-PCR gmvA 
GM319 AAAACAGACAGCGCAAGAAG qRT-PCR repA 
GM320 CCGTCTAGCTCTCTCTAATCGCTCTGTCTGGTAACTGCGGA qRT-PCR repA 
GM312 
GCGAATTAATACGACTCACTATAGGGCTTAAGTATAAGGAGGAAAAAATATGGGCAGCAGCCATCA
TCATCATCAT PURExpress 
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GmvT 
GM313 AAACCCCTCCGTTTAGAGAGGGGTTATGCTAGTTATCAGACTTTATAAAACAAGGTATT 
PURExpress 
GmvT 
GM314 AGGGGCATGGTTTCGGTAAATGGCTACTAAG 
PURExpress 
GmvTG103D 
GM315 ACCGAAACCATGCCCCTGGGTACAAAC 
PURExpress 
GmvTG103D 
GM332 
GCGAATTAATACGACTCACTATAGGGCTTAAGTATAAGGAGGAAAAAATATGAGCAAAGGAGAAG
AACTTTTCACT 
PURExpress 
sfGFP 
GM333 AAACCCCTCCGTTTAGAGAGGGGTTATGCTAGTTATCATTTGTAGAGCTCATCCATGCC 
PURExpress 
sfGFP 
GM336 CGCACGTTCGTTATTTGCTT qRT-PCR gmvT 
GM337 CCGTCTAGCTCTCTCTAATCGAACAACAGGGACAGGATTGG qRT-PCR gmvT 
GM338 
GCGAATTAATACGACTCACTATAGGGCTTAAGTATAAGGAGGAAAAAATATGCATCATCATCATCAT
CACAGCAGCGGCATGGGATGTGTAACTGCACCAGAACCT 
PURExpress 
pWR501_0111 
GM339 AAACCCCTCCGTTTAGAGAGGGGTTATGCTAGTTACTATTGAGGGAGTTTAAGAAACAA 
PURExpress 
pWR501_0111 
qRT_Tag CCGTCTAGCTCTCTCTAATCG qRT-PCR 
 
 
